V

Vor Biopharma Inc
NASDAQ:VOR

Watchlist Manager
Vor Biopharma Inc
NASDAQ:VOR
Watchlist
Price: 15.82 USD 17.1% Market Closed
Market Cap: 257.5m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of VOR.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VOR Intrinsic Value
Not Available
V
Base Case Scenario
Compare VOR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VOR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vor Biopharma Inc

Current Assets 172.5m
Cash & Short-Term Investments 170.5m
Other Current Assets 2m
Non-Current Assets 3.8m
PP&E 3.3m
Other Non-Current Assets 437k
Current Liabilities 18.8m
Accounts Payable 885k
Accrued Liabilities 18m
Non-Current Liabilities 2.4B
Other Non-Current Liabilities 2.4B
Efficiency

Free Cash Flow Analysis
Vor Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vor Biopharma Inc

Revenue
0 USD
Operating Expenses
-367m USD
Operating Income
-367m USD
Other Expenses
-2.1B USD
Net Income
-2.4B USD
Fundamental Scores

VOR Profitability Score
Profitability Due Diligence

Vor Biopharma Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
33/100
Profitability
Score

Vor Biopharma Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

VOR Solvency Score
Solvency Due Diligence

Vor Biopharma Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
47/100
Solvency
Score

Vor Biopharma Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VOR Price Targets Summary
Vor Biopharma Inc

Wall Street analysts forecast VOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VOR is 40.8 USD with a low forecast of 9.09 USD and a high forecast of 67.2 USD.

Lowest
Price Target
9.09 USD
43% Downside
Average
Price Target
40.8 USD
158% Upside
Highest
Price Target
67.2 USD
325% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Vor Biopharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VOR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

VOR Insider Trading
Buy and sell transactions by insiders